Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raderer

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimenM Raderer, G V Kornek, M H Hejna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancerM Raderer, A Kurtaran, Q Yang, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
Anticancer Research|November 20, 2001
Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysisM Z Penz, W C Fiebiger, J B Valencak, et al.
British Journal of Cancer|November 27, 2001
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-typeM Raderer, T Traub, M Formanek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Anticancer Research|January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic cloneS Wöhrer, W Rabitsch, M Shehata, et al.
Anticancer Research|June 9, 2001
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tractM Hejna, G Hamilton, T Brodowicz, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimenM Raderer, G V Kornek, M H Hejna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 23, 1998
Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancerM Raderer, A Kurtaran, Q Yang, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
Anticancer Research|November 20, 2001
Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysisM Z Penz, W C Fiebiger, J B Valencak, et al.
British Journal of Cancer|November 27, 2001
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-typeM Raderer, T Traub, M Formanek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Anticancer Research|January 30, 2008
Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic cloneS Wöhrer, W Rabitsch, M Shehata, et al.
Anticancer Research|June 9, 2001
Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tractM Hejna, G Hamilton, T Brodowicz, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
Pageof 18